Search the Appendices of Resolution CM/Res(2018)1
1905 found
INN | ATC Code ▲ | Country | Classification | Last update | MA Number | Registration date | Status | |
---|---|---|---|---|---|---|---|---|
ADAGRASIB | L01XX77 | SI | POM | 23-04-2025 | EMEA/H/C/006013 | 05-01-2024 | VALID | |
MEGESTROL | L02AB01 | SI | I | 5363-I-452/05 | 14-06-2005 | VALID | ||
MEDROXYPROGESTERONE | L02AB02 | SI | POM | 23-04-2025 | VALID | |||
LEUPRORELIN | L02AE02 | SI | POM | 09-05-2019 | 5363-I-618/05 | 23-08-2005 | VALID | |
TAMOXIFEN | L02BA01 | SI | POM | 17-06-2019 | 5363-I-18/04 | 15-01-2004 | VALID | |
FULVESTRANT | L02BA03 | SI | POM | VALID | ||||
FLUTAMIDE | L02BB01 | SI | I | 23-04-2025 | 5363-I-326/02 | 04-07-2002 | VALID | |
ENZALUTAMIDE | L02BB04 | SI | POM | 14-11-2023 | None | VALID | ||
APALUTAMIDE | L02BB05 | SI | POM | VALID | ||||
ANASTROZOLE | L02BG03 | SI | I | 5363-I-517/03 | 15-07-2003 | VALID | ||
LETROZOLE | L02BG04 | SI | I | 5363-I-213/03 | 18-07-2003 | VALID | ||
EXEMESTANE | L02BG06 | SI | I | 512/B-443/01 | 10-12-2001 | VALID | ||
ABARELIX | L02BX01 | SI | Not authorised | VALID | ||||
ABIRATERONE | L02BX03 | SI | POM | VALID | ||||
FILGRASTIM | L03AA02 | SI | POM | VALID | ||||
PEGFILGRASTIM | L03AA13 | SI | POM | 23-04-2025 | VALID | |||
LIPEGFILGRASTIM | L03AA14 | SI | POM | VALID | ||||
INTERFERON BETA-1A | L03AB07 | SI | I | 5363-I-829/03 | 23-12-2003 | VALID | ||
INTERFERON BETA-1B | L03AB08 | SI | I | 5363-I-656/03 | 14-10-2003 | VALID | ||
ROPEGINTERFERON ALFA-2B | L03AB15 | SI | POM | VALID | ||||
ALDESLEUKIN | L03AC01 | SI | Not authorised | VALID | ||||
LENTINAN | L03AX01 | SI | Not authorised | VALID | ||||
GLATIRAMER ACETATE | L03AX13 | SI | POM | VALID | ||||
PLERIXAFOR | L03AX16 | SI | POM | 14-11-2023 | None | VALID | ||
ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) | L04AA04 | SI | POM | VALID | ||||
ABATACEPT | L04AA24 | SI | POM | VALID | ||||
CLADRIBINE | L04AA40 | SI | POM | 21-02-2020 | VALID | |||
ETANERCEPT | L04AB01 | SI | POM | 13-04-2017 | 5363-I-539/03 | 11-08-2003 | VALID | |
INFLIXIMAB | L04AB02 | SI | POM | VALID | ||||
ADALIMUMAB | L04AB04 | SI | POM | VALID | ||||
CERTOLIZUMAB PEGOL | L04AB05 | SI | POM | VALID | ||||
GOLIMUMAB | L04AB06 | SI | POM | VALID | ||||
DACLIZUMAB | L04AC01 | SI | Not authorised | VALID | ||||
RISANKIZUMAB | L04AC18 | SI | POM | VALID | ||||
SPESOLIMAB | L04AC22 | SI | POM | 18-08-2023 | EMEA/H/C/005874 | 09-12-2022 | VALID | |
MIRIKIZUMAB | L04AC24 | SI | POM | 14-11-2023 | EMEA/H/C/005122 | 26-05-2023 | VALID | |
CICLOSPORIN | L04AD01 | SI | POM | VALID | ||||
TACROLIMUS | L04AD02 | SI | POM | 13-11-2018 | VALID | |||
FINGOLIMOD | L04AE01 | SI | POM | VALID | ||||
SIPONIMOD | L04AE03 | SI | POM | VALID | ||||
ETRASIMOD | L04AE05 | SI | POM | 13-05-2024 | EMEA/H/C/006007 | 16-02-2024 | VALID | |
TOFACITINIB | L04AF01 | SI | POM | VALID | ||||
BARICITINIB | L04AF02 | SI | POM | VALID | ||||
UPADACITINIB | L04AF03 | SI | POM | VALID | ||||
DEUCRAVACITINIB | L04AF07 | SI | POM | 18-08-2023 | EMEA/H/C/005755 | 24-03-2023 | VALID | |
RITLECITINIB | L04AF08 | SI | POM | 14-11-2023 | EMEA/H/C/006025 | 15-09-2023 | VALID | |
ALEMTUZUMAB | L04AG06 | SI | POM | 23-04-2025 | VALID | |||
OCRELIZUMAB | L04AG08 | SI | POM | VALID | ||||
OFATUMUMAB | L04AG12 | SI | POM | VALID | ||||
UBLITUXIMAB | L04AG14 | SI | POM | 14-11-2023 | EMEA/H/C/005914 | 31-05-2023 | VALID |